Lexpos News

In line with our new branding, we have produced new resources for pharmacy owners to promote the Flu Vaccination Service to their patients. A variety of resources are available including letters, posters, flyers and social media template tweets and tiles. These can also be accessed via our flu hub page at cpe.org.uk/flu under the ‘Promoting [...]

The post New promotional materials for the Flu Vaccination Service appeared first on Community Pharmacy England.

Community Pharmacy England has become aware of a discrepancy in the pack size listings for Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension. This suspension is currently marketed in 100ml and 250ml pack sizes by Bayer Plc. However, these volumes represent the actual bottle sizes and not the final reconstituted volumes of the product. This may create confusion [...]

The post Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension pack size discrepancy appeared first on Community Pharmacy England.

Pharmacy press Following the Government announcement of new funding for winter pressures, we were asked whether any of this would be made available to the community pharmacy sector. Government press release: £200 million to boost NHS resilience and care this winter Our Chief Executive Janet Morrison said: “Community pharmacies consistently play a vital role in [...]

The post Funding for winter pressures appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Midazolam (Epistatus®) 2.5mg/0.25ml and 10mg/1ml oromucosal solution pre-filled oral syringes. MSN/2023/086 Tier 2 – medium impact Date of issue 14th September 2023 Midazolam (Epistatus®) 2.5mg/0.25ml and 10mg/1ml oromucosal solution pre-filled oral syringes are out of stock until late November 2023. Midazolam [...]

The post Medicine Supply Notification: Midazolam (Epistatus® ) 2.5mg/0.25ml and 10mg/1ml oromucosal solution pre-filled oral syringes appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (FemSeven®) 75micrograms/24hours and 100micrograms/24hours transdermal patches. MSN/2023/085 Tier 2 – medium impact Date of issue 14th September 2023 Estradiol (FemSeven®) 75micrograms/24hours and 100micrograms/24hours transdermal are out of stock until w/c 2nd October 2023. Alternative brands of estradiol patches, Evorel® and [...]

The post Medicine Supply Notification: Estradiol (FemSeven® ) 75micrograms/24hours and 100micrograms/24hours transdermal patches appeared first on Community Pharmacy England.